The transaction supports Embecta’s plan to diversify by supplying drug delivery solutions to pharmaceutical partners.

Embecta closed its acquisition of Owen Mumford Holdings on Friday, shifting its focus from diabetes products to broader ...

Embecta (Nasdaq:EMBC) announced that it completed its previously announced acquisition of Owen Mumford Holdings Limited.

Pirouette aims to use their patented technology to revolutionize the $600B injectable medicine market, making life-saving injections as easy as pushing a button PORTSMOUTH, N.H.–(BUSINESS WIRE)–May 7, ...

Embecta has signed a definitive agreement to acquire UK-based Owen Mumford Holdings for up to £150m ($172.6m), to enhance its global presence in drug delivery technologies. The agreement includes an ...

Richmond, VA, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-delivery device technology and auto-injectors, today announced the appointment of Ram Halthore as Vice President, ...

DETROIT & BOSTON--(BUSINESS WIRE)--Sempresto, Inc., a medical device company pioneering smartphone integrated rescue drug delivery, today announced the acquisition of Alerje’s mobile device integrated ...

(RTTNews) - Ypsomed Holding AG (YPHDF) announced Monday that its digital connectivity add-on, SmartPilot, has received 510(k) clearance from the U.S. Food and Drug Administration or FDA. SmartPilot ...

Sempresto, Inc., a company developing a next-generation platform for smartphone-integrated rescue medications, today announced that it has been featured in a recent Inc. article by Chloe Capital, ...

An announcement from Embecta Corporation ( (EMBC)) is now available. On May 15, 2026, Embecta completed its acquisition of Owen Mumford Holdings Limited, following a March 19, 2026 purchase agreement ...

PORTSMOUTH, N.H.--(BUSINESS WIRE)--Pirouette, with their innovative auto-injector platform, announced they have surpassed $5M raised in their community investment round on Wefunder, prompting them to ...